{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:31Z","timestamp":1746331651398,"version":"3.40.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Castleman disease, also known as Castleman syndrome, is a rare, nonmalignant lymphoproliferative disorder. The localized subtype of this disease is primarily the hyaline vascular type of Castleman disease (HVCD). Although this disease is a benign lesion, the histologic features are similar to those of some malignant lymphomas, so an accurate diagnosis of the disease is required. Lymph node hyperplasia lesions are usually diagnosed mainly by relying on biopsy histopathology, but the surgical process is time-consuming and expensive, and a part of patients usually refuse to undergo this examination method. Fine-needle aspiration cytology (FNAC) is a convenient, rapid, minimally invasive test for surface masses, and patients often receive cytopathology results in as little as a few minutes. Currently, there are few reports on the pathological features of FNAC in HVCD, so our cytopathological experience of using FNAC for rapid diagnosis of HVCD and other diseases that need to be differentiated are described in detail to give some meaningful references to the pathologists in recognizing HVCD from a rare cytological point of view.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A late 50s female patient presented to the hospital with a single subcutaneous enlarged nodule in the right side of the neck, which had been present for &gt;6 months. The nodule exhibited a relatively clear border, and the patient presented with no signs of pain, no skin damage, and no other notable symptoms, but was concerned about the benignity or malignancy of the enlarged nodule.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>To determine the exact diagnosis of the neck nodule, the patient first underwent FNAC, followed by surgical excision of the neck nodule for histopathologic examination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Since HVCD is a benign lesion and the superficial neck nodes were removed by minimally invasive surgery, the patient did not receive any other interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>We successfully and accurately diagnosed the rare HVCD using FNAC. Histologically similar lesion features of HVCD were successfully observed in cytology. The cytologic pattern of HVCD is distinctly different from that of other benign lymphoid tissue proliferative lesions or metastatic carcinomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case shows important cytologic features for the diagnosis of HVCD using FNAC. The FNAC results showed abundant follicular dendritic cells and transparent blood vessels, and these cytologic features recapitulate the histopathologic alterations that were seen in HVCD. So by observing these cytologic features can help us to make an accurate diagnosis of HVCD using FNAC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040972","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:02:55Z","timestamp":1734724975000},"page":"e40972","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A rare perspective: fine-needle aspiration cytologic features of hyaline vascular type of Castleman disease: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5126-7753","authenticated-orcid":false,"given":"Xiang","family":"Shi","sequence":"first","affiliation":[{"name":"Departments of Pathology, Qianjiang Central Hospital, Qianjiang, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyuan","family":"Wangsun","sequence":"additional","affiliation":[{"name":"Nanchang University Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiping","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Qianjiang Central Hospital, Qianjiang, Hubei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanyan","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Qianjiang Central Hospital, Qianjiang, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05311.x","article-title":"The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.","volume":"129","author":"Casper","year":"2005","journal-title":"Br J Haematol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hoc.2017.09.006","article-title":"Unicentric Castleman disease.","volume":"32","author":"Wong","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease.","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease.","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"339","DOI":"10.32074\/1591-951X-351","article-title":"Multicentric Castleman disease and the evolution of the concept.","volume":"113","author":"Zhou","year":"2021","journal-title":"Pathologica"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/diagnostics11112008","article-title":"Clinical and pathological characteristics of hyaline-vascular type unicentric Castleman disease: a 20-year retrospective analysis.","volume":"11","author":"Nishimura","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cyt.12836","article-title":"Role of fine needle aspiration cytology in the diagnosis of soft tissue tumours.","volume":"31","author":"Domanski","year":"2020","journal-title":"Cytopathology"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/jcp.30662","article-title":"Follicular dendritic cells.","volume":"237","author":"Abd El-Aleem","year":"2022","journal-title":"J Cell Physiol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000526640","article-title":"Recent advances in Castleman disease.","volume":"45","author":"Hoffmann","year":"2022","journal-title":"Oncol Res Treat"},{"key":"R10-20250503","first-page":"314","article-title":"A rare lymphoproliferative disease: Castleman disease.","volume":"38","author":"G\u00fcnd\u00fcz","year":"2021","journal-title":"Turk J Haematol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"e27613","DOI":"10.1002\/pbc.27613","article-title":"Castleman disease in pediatrics: insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.","volume":"66","author":"Sopfe","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease.","volume":"32","author":"Wu","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.6004\/jnccn.2019.5037","article-title":"Diagnosis and management of Castleman disease.","volume":"17","author":"Abramson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jcp.51.3.197","article-title":"Fine needle aspiration cytology diagnosis of malignant lymphoma and reactive lymphoid hyperplasia.","volume":"51","author":"Stewart","year":"1998","journal-title":"J Clin Pathol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/dc.23402","article-title":"Diagnostic value of liquid-based cytology with fine needle aspiration specimens for cervical lymphadenopathy.","volume":"44","author":"Bandoh","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000519074","article-title":"Application of Hans algorithm for subcategorization of diffuse large B-cell lymphoma in fine-needle aspiration biopsy cytology.","volume":"66","author":"Rohilla","year":"2022","journal-title":"Acta Cytol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5455\/msm.2024.36.18-22","article-title":"Fine needle aspiration cytology of lymph nodes in metastatic cancer and lymphoma: our single-institution experience.","volume":"36","author":"Vesnic","year":"2024","journal-title":"Mater Sociomed"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjh.15788","article-title":"Lymphoma diagnostics: getting more from less.","volume":"185","author":"Galardy","year":"2019","journal-title":"Br J Haematol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/107327481402100403","article-title":"Diagnosis and management of Castleman disease.","volume":"21","author":"Soumerai","year":"2014","journal-title":"Cancer Control"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2011-09-377705","article-title":"HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.","volume":"119","author":"Suthaus","year":"2012","journal-title":"Blood"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"bcr2012006756","DOI":"10.1136\/bcr-2012-006756","article-title":"Castleman\u2019s disease in a patient with melanoma: the role of VEGF.","volume":"2012","author":"Shahani","year":"2012","journal-title":"BMJ Case Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:29:00Z","timestamp":1746318540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":21,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040972","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}